March 2017 – WTO TRIPS Council – Brazil’s statement on copyright and e-commerce
At the March 2017 session of the WTO TRIPS Council, Brazil delivered the following statement on copyright and e-commerce.
1 March 2017 – WTO TRIPS Council – India’s statement on Non-Violation and Situation Complaints
On 1 March 2017, India delivered the following intervention on Non-Violation and Situation Complaints at the WTO TRIPS Council.
Agenda Item 8. Non-Violation and Situation ComplaintsMr.Chairman, my delegation would like to thank the delegation of Kyrgyz Republic for joining as co-sponsor of document W385 Rev.1.
1 March 2017 – WTO TRIPS Council – India’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On 1 March 2017, India delivered the following statement during WTO TRIPS Council discussions on the United Nations Secretary-General’s High Level Panel Report on Access to Medicines.
Agenda item 12: the United Nations Secretary-General’s High Level Panel Report on Access to MedicinesThank you Chairman.
At the outset, I would like to thank delegations of Brazil, China and South Africa who are also co-sponsors of this agenda item.
1 March 2017 – WTO TRIPS Council – Brazil’s intervention on the Report of the UN High-Level Panel on Access to Medicines
On 1 March 2017, Brazil delivered the following statement during WTO TRIPS Council discussions on the Report of the United Nations High-Level Panel on Access to Medicines.
High Level PanelAs we all know, on 19 November 2015, United Nations Secretary General Ban Ki-moon announced the creation of the High-Level Panel on Innovation and Access to Health Technologies. Responding to this invitation, two chairs were designated to the panel, namely, Ms. Ruth Dreifuss, from Switzerland, and Festus Mogae, from Botswana.
MEP Lola Sánchez questions the European Commission: EU’s position on the UN High-Level Panel on Access to Medicines at WIPO
On 2 February 2017, MEP Lola Sánchez Caldentey (Podemos, Spain) tabled a series of written questions to the European Commission on the positions taken by the European Union at the World Intellectual Property Organization on 14 December 2016 in relation to the United Nations High-Level Panel on Access to Medicines (UN HLP)
WTO TRIPS Council: Brazilian submission on Ecommerce and Copyright
In December 2016, Brazil submitted a proposal to the World Trade Organization entitled, ELECTRONIC COMMERCE AND COPYRIGHT (JOB/GC/113, JOB/IP/19), intended for circulation at the WTO’s General Council and the TRIPS Council. This paper will be discussed at the next session of the TRIPS Council under agenda item 13, “Work Programme on Electronic Commerce” (1-2 March 2017).
WTO Trade Policy Review: Members question the United States on compulsory licensing, Bayh-Dole, UNHLP & Section 337
In December 2016, during the twilight of President Barack Obama’s 44th presidency, the World Trade Organization (WTO) conducted a Trade Policy Review (TPR) of the United States of America. All members of the WTO are subject to review under the Trade Policy Review Mechanism (TPRM). The TPRM takes place in the “Trade Policy Review Body which is actually the WTO General Council — comprising the WTO’s full membership — operating under special rules and procedures” (Source: WTO, Trade Policy Reviews: Brief Introduction).
EB140: WHO adopts decision on terms of reference for overall programme review of the GSPOA (31 Jan 2017)
On 31 January 2017 the WHO Secretariat published the “Draft decision resulting from informal consultations” on the Overall programme review of the global strategy and plan of action on public health, innovation and intellectual property (EB140/CONF./7 Rev.1). This can be found here: http://apps.who.int/gb/ebwha/pdf_files/EB140/B140_CONF7Rev1-en.pdf
The chapeau to this decision notes:
EB140 heats up during discussions of proposed changes to resolution on TOR of Overall Programme Review of GSPOA
* (The author thanks the PHM Watchers for their notes of the WHO EB140 deliberations).
EB140: Statement of India on the Report of the United Nations High-Level Panel on Access to Medicines
On the morning of Monday, 23 January 2017, India delivered the following intervention at the 140th session of the World Health Organization’s Executive Board requesting the “explicit inclusion” of the United Nations Secretary-General’s High-Level Panel Report in the “provisional agenda of the EB140 as a separate agenda item under item 8.”
In making the case for the inclusion of the UN HLP in the WHO’s Executive Board deliberations, India articulate the following: